Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma

Oncotarget. 2023 Jul 1:14:668. doi: 10.18632/oncotarget.28471.
No abstract available

Publication types

  • Published Erratum